Saturday, July 18, 2020

Biovacc-19 - The researchers are now in the process of developing their own version of a vaccine, which will be produced by the Norwegian drug company Immunor AS.

https://atlantabusinessjournal.com/sars-cov-2-origin-deadliest-cover-up-in-human-history/
https://atlantabusinessjournal.com/sars-cov-2-origin-deadliest-cover-up-in-human-history/

They also point out that choosing an adjuvant after the primary vaccine design work has been completed, which is how vaccine development is typically done, may be yet another serious mistake that could make a COVID-19 vaccine really dangerous.

For all of these reasons, the researchers are now in the process of developing their own version of a vaccine, which will be produced by the Norwegian drug company Immunor AS. Dearlove believes this paper may finally shift the debate on SARS-CoV-2’s origin.

According to The Telegraph,25,26 in an earlier version the paper, which has reportedly been rewritten several times, Sorensen et al. claimed they had proven “beyond reasonable doubt that the COVID-19 virus is engineered.” That statement is no longer included in the paper.

+++

https://www.editorials360.com/2020/07/17/nobel-laureate-calls-covid-19-artifical/

+++

https://techadvices.net/former-mi6-director-says-coronavirus-is-an-accident-from-a-chinese-lab-bgr/

Here’s the complete summary of the analyze, titled Biovacc-19: A Applicant Vaccine for Covid-19 (SARS-CoV-2) Formulated from Investigation of its General Process of Motion for Infectivity, as posted final 7 days on Immunor’s internet site — emphasis ours:

“This analyze provides the track record, rationale and Process of Motion of Biovacc-19, a prospect vaccine for Covid-19, now in highly developed pre-clinical advancement, which has previously handed the 1st acute toxicity screening. As opposed to conventionally produced vaccines, Biovacc-19’s Process of Procedure is on non human-like (NHL) epitopes in 21.6% of the composition of SARS-CoV-2’s Spike protein, which displays distinctive distributed demand such as the existence of a billed furin-like cleavage internet site. The logic of the structure of the vaccine is explained, which starts off with empirical assessment of the aetiology of SARS-CoV-2. Mistaken assumptions about SARS-CoV-2’s aetiology threat making ineffective or actively unsafe vaccines, such as the threat of Antibody-Dependent Improvement (ADE). This sort of troubles in vaccine structure are illustrated from earlier experience in the HIV area. We propose that the twin impact basic process of motion of this chimeric virus’s spike, such as receptor binding area, features membrane parts other than the ACE2 receptor, which clarifies clinical evidence of its infectivity and pathogenicity. We demonstrate the non-receptor dependent phagocytic basic process of motion to be exclusively associated to cumulative demand from inserted sections placed on the SARS-CoV-2 Spike surface in positions to bind effectively by salt bridge formations and from blasting the Spike we show the non human-like epitopes from which Biovacc-19 has been down-selected.”

#Biovacc19 #Biovacc #SARSCoV2

[Given the latest news that a traditional covid vaccine probably ain't gonna happen, perhaps this #Biovacc19 might work? IDK]

No comments:

Post a Comment